Family Practice News Digital Network According to the FDA, 23 million outpatients were prescribed an oral quinolone in 2011. A total of 70% received ciprofloxacin; 28% were prescribed levofloxacin; and 9% were given moxifloxacin. Gemifloxacin, ofloxacin, and norfloxacin each accounted for ... and more »
MarketWatch FACTIVE(R) is an FDA-approved quinolone with 5-day oral dosing indicated for the treatment of both acute bacterial exacerbation of chronic bronchitis and mild to moderate community-acquired pneumonia. Pursuant to the definitive agreements, Merus ... and more »
Philly.com (blog) This adverse effect has been known about for some time. In fact, the risk was added to the fine print of professional labeling (package insert) in 2004. But patients for whom a quinolone is prescribed don't ordinarily receive the package insert and ...
Family Practice News Digital Network According to the FDA, 23 million outpatients were prescribed an oral quinolone in 2011. A total of 70% received ciprofloxacin; 28% were prescribed levofloxacin; and 9% were given moxifloxacin. Gemifloxacin, ofloxacin, and norfloxacin each accounted for ... and more »
